[go: up one dir, main page]

BR9714588A - Diidropironas com atividade antiviral incrementada - Google Patents

Diidropironas com atividade antiviral incrementada

Info

Publication number
BR9714588A
BR9714588A BR9714588-2A BR9714588A BR9714588A BR 9714588 A BR9714588 A BR 9714588A BR 9714588 A BR9714588 A BR 9714588A BR 9714588 A BR9714588 A BR 9714588A
Authority
BR
Brazil
Prior art keywords
antiviral activity
dihydropyrones
increased antiviral
increase
increased
Prior art date
Application number
BR9714588-2A
Other languages
English (en)
Inventor
Frederick Earl Boyer Jr
John Michael Domagala
Edmund Lee Ellsworth
Christopher Andrew Gajda
Susan Elizabeth Hagen
Harriet Wall Hamilton
Larry James Markoski
Josyula Venkata Nagendr Prasad
Bradle Dean Tait
Elizabeth Ann Lunney
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR9714588A publication Critical patent/BR9714588A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/04—Thiosulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção:<B>"DIIDROPIRONAS COM ATIVIDADE ANTIVIRAL INCREMENTADA"<D>. A presente invenção diz respeito à atividade antiviral aumentada de 6,6-dissubstituídas-5-6-diidropiran-2-onas causada pela colocação abalizada de certos substituintes polares nas posições 3 e/ou 6. Os mesmos substituintes que aumentam a atividade celular também diminuem a citotoxidade de modo a incrementar as propriedades desejáveis desses agentes como antivirais.
BR9714588-2A 1996-11-01 1997-10-31 Diidropironas com atividade antiviral incrementada BR9714588A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2990696P 1996-11-01 1996-11-01
US08/883,743 US5834506A (en) 1996-11-01 1997-06-27 Dihydropyrones with improved antiviral activity
PCT/US1997/019853 WO1998019997A2 (en) 1996-11-01 1997-10-31 Dihydropyrones with improved antiviral activity

Publications (1)

Publication Number Publication Date
BR9714588A true BR9714588A (pt) 2000-05-30

Family

ID=26705464

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714588-2A BR9714588A (pt) 1996-11-01 1997-10-31 Diidropironas com atividade antiviral incrementada

Country Status (18)

Country Link
US (2) US5834506A (pt)
EP (1) EP0935597A2 (pt)
JP (1) JP2001504102A (pt)
KR (4) KR20000052951A (pt)
AU (1) AU733700B2 (pt)
BR (1) BR9714588A (pt)
CA (1) CA2263429A1 (pt)
CO (1) CO4910146A1 (pt)
HR (1) HRP970571A2 (pt)
IL (1) IL128517A (pt)
MX (1) MXPA99001777A (pt)
MY (1) MY118131A (pt)
NO (1) NO992103L (pt)
NZ (2) NZ507184A (pt)
PE (1) PE13799A1 (pt)
PL (1) PL332904A1 (pt)
TW (1) TW536536B (pt)
WO (1) WO1998019997A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014210A1 (en) * 1997-09-15 1999-03-25 Warner-Lambert Company Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
US6528510B1 (en) 1998-09-11 2003-03-04 Warner-Lambert Company HIV protease inhibitors
US6380400B1 (en) 1998-09-11 2002-04-30 Victor Fedij Methods of making dihydropyrone HIV protease inhibitors
US6054623A (en) * 1998-12-18 2000-04-25 Alliedsignal Inc. Hydroxythiol grignard reaction synthesis
US6512006B1 (en) 1999-12-09 2003-01-28 Warner-Lambert Company HIV protease inhibitors
WO2002020509A2 (de) * 2000-09-06 2002-03-14 Bayer Aktiengesellschaft Arzneimittel gegen virale erkrankungen
US7141681B2 (en) 2001-02-22 2006-11-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Continuous process for preparing dihydropyrones
DE10108471C1 (de) 2001-02-22 2002-11-21 Boehringer Ingelheim Pharma Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen
EP1377549A1 (en) * 2001-03-12 2004-01-07 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
DE10257761A1 (de) 2002-12-10 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung optisch aktiver Dihydropyrone
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
HRP20110458T1 (hr) * 2004-08-18 2011-07-31 Pfizer Inc. Inhibitori rna-ovisne rna-polimeraze iz virusa hepatitisa c, te pripravci i liječenje u kojem se koriste
HRP20140015T1 (hr) 2007-12-20 2014-02-14 Pharma Mar, S.A. Antitumorski spojevi
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57167296A (en) * 1981-04-09 1982-10-15 Ricoh Co Ltd Heat-sensitive recording material
RU2160733C2 (ru) * 1993-11-19 2000-12-20 Парк, Дэвис энд Компани Производные пирона и их фармацевтически приемлемые соли, промежуточные соединения для их получения, фармацевтическая композиция с антивирусной и антибактериальной активностью на их основе, способ лечения вызванных ретровирусом инфекции или заболевания
FI962022L (fi) * 1993-11-19 1996-07-12 Parke Davis & Co 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
US5834506A (en) 1998-11-10
KR20040104644A (ko) 2004-12-10
HRP970571A2 (en) 1998-08-31
WO1998019997A3 (en) 1998-08-27
AU5100198A (en) 1998-05-29
NZ507184A (en) 2002-02-01
KR20040104646A (ko) 2004-12-10
NZ334701A (en) 2001-01-26
CO4910146A1 (es) 2000-04-24
EP0935597A2 (en) 1999-08-18
AU733700B2 (en) 2001-05-24
MXPA99001777A (es) 2003-08-10
TW536536B (en) 2003-06-11
KR100496365B1 (ko) 2005-06-21
US6046355A (en) 2000-04-04
IL128517A (en) 2003-07-31
CA2263429A1 (en) 1998-05-14
NO992103D0 (no) 1999-04-30
JP2001504102A (ja) 2001-03-27
KR20000052951A (ko) 2000-08-25
PL332904A1 (en) 1999-10-25
PE13799A1 (es) 1999-02-26
MY118131A (en) 2004-09-30
KR100496366B1 (ko) 2005-06-21
IL128517A0 (en) 2000-01-31
KR100496367B1 (ko) 2005-06-22
NO992103L (no) 1999-04-30
WO1998019997A2 (en) 1998-05-14
KR20040104645A (ko) 2004-12-10

Similar Documents

Publication Publication Date Title
BR9714588A (pt) Diidropironas com atividade antiviral incrementada
FI953748A7 (fi) Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksi danttiaktiivisuus sekä niiden käyttö solua suojaavina aineina
DE69314025D1 (de) Zusammensetzungen mit kühleffekt
BR9905852A (pt) Poliuretanos termoplásticos alifáticos, processo para sua preparação e seu emprego
ES2165122T3 (es) Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
IT1200092B (it) Derivati amminopropossi, loro preparazione e loro impiego come medicamenti
BRPI0412411A (pt) tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
ES271784U (es) Casco protector de la cabeza perfeccionado.
DE3769683D1 (de) Farblose ketimine, ihre herstellung und ihre verwendung als vernetzungsmittel.
BG43856A3 (bg) Метод за борба с протозои
BR0005709A (pt) Pneumático para fora de estrada
ES2143666T3 (es) P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales.
ATE145550T1 (de) Neue zusammensetzungen
EA199900450A1 (ru) Агент, индуцирующий апоптоз
IT1214648B (it) 8 alfa-acilamminoergoline,loro preparazione e loro impiego come medicamenti
BR0013221A (pt) Chá preto de folha
IT9047666A0 (it) Ftalocianine, loro preparazione e loro impiego come coloranti.
IT1211945B (it) Ossalanidi,loro preparazione e loro impiego come stabilizzanti delle materie polimere
IT1203816B (it) Disaccaridi,loro preparazione e loro impiego come medicamenti
BR9809746A (pt) Compostos de éteres oxìmicos, seu uso e intermediários para preparações dos mesmos.
ES2181787T3 (es) Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos
IT8848041A0 (it) Benzoil-2h-piran-3,5-4h,6h-diodi sostituiti, loro preparazione e loro impiego come erbicidi,
FI870669A7 (fi) 2-syaani-bentsimidatsolin uudet johdannaiset, niiden valmistus ja käyttö sieniä tuhoavana aineena, niiden yhdistäminen muihin sieniä tuhoaviin aineisiin.
AR023668A1 (es) Nuevos derivados de benzoilguanidina con ventajosas propiedades, procedimiento para su preparacion y su utilizacion en la preparacion de medicamentos
WO1998016522A3 (de) Aminophenolderivate mit fungizider wirkung

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]